Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Allez

Showing results (141-150 of 205) with videos related to

Pageof 21
Sort By:
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor AgentsPauline Wils, Yoram Bouhnik, Pierre Michetti, et al.
Gastroenterology|November 19, 2008
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type IIGeorgia Malamut, Pauline Afchain, Virginie Verkarre, et al.
Gut|July 8, 2022
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibitionJulie Bonnereau, Tristan Courau, Nicolas Asesio, et al.
The American Journal of Gastroenterology|August 16, 2022
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAIDGilles Boschetti, Maria Nachury, David Laharie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2017
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained RemissionCatherine Reenaers, Jean-Yves Mary, Maria Nachury, et al.
Plos One|January 10, 2013
Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphismsCamille Jung, Jean-Frédéric Colombel, Marc Lemann, et al.
United European Gastroenterology Journal|November 18, 2021
Faster and less invasive tools to identify patients with ileal colonization by adherent-invasive E. coli in Crohn's diseaseAnthony Buisson, Emilie Vazeille, Mathurin Fumery, et al.
Journal of Crohn'S & Colitis|January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort StudyAntoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|November 22, 2024
Development and Validation of a Sexual Quality of Life Score for Youths With Inflammatory Bowel DiseaseAlexandre Mancheron, Agnès Dumas, Isabelle Nion Larmurier, et al.
Pageof 21

Showing results (141-150 of 205) with videos related to

Sort By:
Pageof 21
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 4, 2015
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor AgentsPauline Wils, Yoram Bouhnik, Pierre Michetti, et al.
Gastroenterology|November 19, 2008
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type IIGeorgia Malamut, Pauline Afchain, Virginie Verkarre, et al.
Gut|July 8, 2022
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibitionJulie Bonnereau, Tristan Courau, Nicolas Asesio, et al.
The American Journal of Gastroenterology|August 16, 2022
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAIDGilles Boschetti, Maria Nachury, David Laharie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2017
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained RemissionCatherine Reenaers, Jean-Yves Mary, Maria Nachury, et al.
Plos One|January 10, 2013
Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphismsCamille Jung, Jean-Frédéric Colombel, Marc Lemann, et al.
United European Gastroenterology Journal|November 18, 2021
Faster and less invasive tools to identify patients with ileal colonization by adherent-invasive E. coli in Crohn's diseaseAnthony Buisson, Emilie Vazeille, Mathurin Fumery, et al.
Journal of Crohn'S & Colitis|January 14, 2020
Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation: A Multicentre Cohort StudyAntoine Martin, Maria Nachury, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis|November 22, 2024
Development and Validation of a Sexual Quality of Life Score for Youths With Inflammatory Bowel DiseaseAlexandre Mancheron, Agnès Dumas, Isabelle Nion Larmurier, et al.
Pageof 21